Skip to main content

Delcath Systems, Inc.

DCTH
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000872912

No open-market purchases or sales by Delcath Systems, Inc. insiders were filed in the last 90 days; 119 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Delcath Systems, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of DCTH: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders2431+7
Shares1.27M5.16M+3.89M (+305.9%)
Value$6.31M$30.0M+$23.6M (+374.7%)

New holders (9)

Institutions that held Delcath Systems, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to DCTH in Q2 2023
InstitutionSharesValue% of portfolio
BVF Inc1,178,787$6.87M0.19%
Vivo Capital, LLC1,178,787$6.87M0.82%
Logos Global Management LP1,178,787$6.87M0.95%
Stonepine Capital Management, LLC378,787$2.10M0.76%
EAM Investors, LLC155,280$905.3K0.17%
Citadel Advisors LLC18,373$107.1K0.00%
Virtu Financial LLC10,921$64.0K0.00%
Quent Capital, LLC320$1.87K0.00%
Royal Bank of Canada89$1.00K0.00%

Sold out (2)

Institutions that held Delcath Systems, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of DCTH in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Ikarian Capital, LLC360,569$1.08M
JPMorgan Chase & Co1,805$10.0K